{"schema_version":"secwatch.filing_event.v1","accession":"0000096943-26-000101","form_type":"8-K","ticker":"TFX","cik":"0000096943","company_name":"TELEFLEX INC","filed_at":"2026-09-08T21:41:08+00:00","discovered_at":"2026-09-09T10:05:00.560667+00:00","generated_at":"2026-09-09T10:05:28.643002+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Teleflex appoints Sean M. Salmon to board; expands to nine directors","bullets":["Sean M. Salmon appointed to Teleflex board effective Sept 8, 2026; board grows from 8 to 9 directors.","Salmon, 61, ex-Medtronic EVP & President of Cardiovascular (fiscal 2025 revenue ~$12.5B), brings 30+ yrs medtech experience.","He also joins Growth and Operating Committee; 8 of 9 directors now independent; one-third of board refreshed in 2026.","Salmon currently independent director at Adagio Medical (Nasdaq: ADGM); no related-party transactions disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0000096943-26-000101","json":"https://secwatch.observer/filing/0000096943-26-000101.json","markdown":"https://secwatch.observer/filing/0000096943-26-000101.md","text":"https://secwatch.observer/filing/0000096943-26-000101.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/96943/000009694326000101/0000096943-26-000101-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/96943/000009694326000101/tfx-20260908.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-09T10:05:28.643002+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}